Cupp G - Search Results

1

Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.

Lichtenstein SJ, De Leon L, Heller W, Marshall B, Cupp G, Foster K, McLean C, Levy S, Stroman DW. Lichtenstein SJ, et al. Among authors: cupp g. J Pediatr Ophthalmol Strabismus. 2012 Mar-Apr;49(2):88-97. doi: 10.3928/01913913-20111101-02. Epub 2011 Nov 8. J Pediatr Ophthalmol Strabismus. 2012. PMID: 22074357

2

Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.

Tauber S, Cupp G, Garber R, Bartell J, Vohra F, Stroman D. Tauber S, et al. Among authors: cupp g. Adv Ther. 2011 Jul;28(7):566-74. doi: 10.1007/s12325-011-0037-x. Epub 2011 Jun 14. Adv Ther. 2011. PMID: 21681652 Clinical Trial.

3

In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.

Stroman DW, Dajcs JJ, Cupp GA, Schlech BA. Stroman DW, et al. Among authors: cupp ga. Surv Ophthalmol. 2005 Nov;50 Suppl 1:S16-31. doi: 10.1016/j.survophthal.2005.06.002. Surv Ophthalmol. 2005. PMID: 16257308 Review.

4

A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.

Kernt K, Martinez MA, Bertin D, Stroman D, Cupp G, Martínez C, Tirado M, Guasch J; International Tobrex2x Group (Eu). Kernt K, et al. Among authors: cupp g. Eur J Ophthalmol. 2005 Sep-Oct;15(5):541-9. Eur J Ophthalmol. 2005. PMID: 16167284 Clinical Trial.

5

A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.

Kernt K, Martinez MA, Bertin D, International Tobrex X Group Eu G, Stroman D, Cupp G, Martinez C, Tirado M, Guasch J. Kernt K, et al. Among authors: cupp g. Eur J Ophthalmol. 2005 Sep - Oct 2005;15(5):541-549. doi: 10.5301/EJO.2008.993. Eur J Ophthalmol. 2005. PMID: 28221457

6

Simulating the Effect of Gut Microbiome on Cancer Cell Growth Using a Microfluidic Device.

Mittal E, Cupp G, Kang YA. Mittal E, et al. Among authors: cupp g. Sensors (Basel). 2023 Jan 22;23(3):1265. doi: 10.3390/s23031265. Sensors (Basel). 2023. PMID: 36772305 Free PMC article.

7

The Applications and Challenges of the Development of In Vitro Tumor Microenvironment Chips.

Johnson A, Reimer S, Childres R, Cupp G, Kohs TCL, McCarty OJT, Kang YA. Johnson A, et al. Among authors: cupp g. Cell Mol Bioeng. 2022 Dec 26;16(1):3-21. doi: 10.1007/s12195-022-00755-7. eCollection 2023 Feb. Cell Mol Bioeng. 2022. PMID: 36660587 Free PMC article. Review.

8

An Inexpensive Cardiovascular Flow Simulator for Cardiac Catheterization Procedure Using a Pulmonary Artery Catheter.

Johnson A, Cupp G, Armour N, Warren K, Stone C, Lee D, Gilbert N, Hammond C, Moore J, Kang YA. Johnson A, et al. Among authors: cupp g. Front Med Technol. 2021 Oct 28;3:764007. doi: 10.3389/fmedt.2021.764007. eCollection 2021. Front Med Technol. 2021. PMID: 35047963 Free PMC article.

9

The noninvasive cardiac evaluation of long-distance runners.

Parker BM, Londeree BR, Cupp GV, Dubiel JP. Parker BM, et al. Among authors: cupp gv. Chest. 1978 Mar;73(3):376-81. doi: 10.1378/chest.73.3.376. Chest. 1978. PMID: 147162

10

[Left ventricular function of the trained heart].

Dubiel JP, Cupp GV, Londeree BR, Parker BM, Martin RH. Dubiel JP, et al. Among authors: cupp gv. Pol Tyg Lek. 1976 Mar 8;31(10):389-92. Pol Tyg Lek. 1976. PMID: 1264840 Polish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page